Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 09 Dec 2025 for Akero Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleSeth Loring Harrison
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Seth Loring Harrison: trading record in brief
This profile gathers the share dealings of Seth Loring Harrison in Akero Therapeutics, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 25 October 2022 to 9 December 2025, the count stands at 10 filings.
Every open-market trade on record is a sale: 6 sales worth €2.3M. Other entries cover 1 share grant.
Most recently, on 9 December 2025, the filings show a transaction in Akero Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Seth Loring Harrison
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
136,301 sharesCommon StockSEC:0001193125-25-312127:0
148,063 sharesCommon StockSEC:0001193125-25-312127:1
9,398 sharesCommon StockSEC:0001193125-25-312127:2
9,398 shares0Common StockSEC:0000950170-25-082310:0
6,322 shares@ US$46.435512.5% of flowCommon StockSEC:0000899243-22-037475:0
20,338 shares@ US$40.27936.2% of flowCommon StockSEC:0000899243-22-034709:0
800 shares@ US$41.12041.5% of flowCommon StockSEC:0000899243-22-034709:1
22,096 shares@ US$40.27939.3% of flowCommon StockSEC:0000899243-22-034709:2
869 shares@ US$41.12041.6% of flowCommon StockSEC:0000899243-22-034709:3
4,515 shares@ US$44.91639.0% of flowCommon StockSEC:0000899243-22-034377:0
10 of 10 declarations
